Pacific Biosciences's total assets for Q4 2024 were $1.26B, a decrease of -12.99% from the previous quarter. PACB total liabilities were $753.85M for the fiscal quarter, a -24.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.